Investor Relations

IR Home

Conformis Profile Image
Corporate Profile
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, or customized, to fit each patient's unique anatomy. Conformis offers a broad line of customized knee and hip implants and customized pre-sterilized, single-use instruments delivered in a single package to the hospital. In clinical studies, Conformis iTotal® CR knee replacement system demonstrated... more >

Stock Quote

Stock Quote
(Common Stock)
Change :  
Volume :
Data as of  

IR Home

more >
Recent News
6/22/20
Conformis Announces 510(k) Clearance for iTotal® Identity PS
iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass. , June 22, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation
5/28/20
Conformis Announces Settlement of Patent Dispute
Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license
more >
Upcoming Events
More events are coming soon.
IR Contact  
Investor Relations
Phone: (781) 374-5598
E-mail: ir@conformis.com
Featured Reports
More information is coming soon.

Data Provided by Refinitiv. Minimum 15 minutes delayed.